These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of C. parvum therapy on intratumoral macrophage subpopulations. McBride WH; Moore K Adv Exp Med Biol; 1982; 155():731-6. PubMed ID: 7158508 [No Abstract] [Full Text] [Related]
4. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma. Woodruff MF; Dunbar N Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671 [TBL] [Abstract][Full Text] [Related]
5. Growth and treatment of B 16 melanoma in hyperglycemic mice. Pavelić J; Benković B; Pavelić K Res Exp Med (Berl); 1980; 177(1):71-8. PubMed ID: 7403688 [TBL] [Abstract][Full Text] [Related]
6. C. parvum treatment of transplanted rat tumours of spontaneous origin. Willmott N; Pimm MV; Baldwin RW Int J Cancer; 1979 Sep; 24(3):323-8. PubMed ID: 385514 [TBL] [Abstract][Full Text] [Related]
7. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum. Hamilton DN; Bell PR Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648 [No Abstract] [Full Text] [Related]
8. Effect of C. parvum and active specific immunotherapy on intracerebral transplants of a murine fibrosarcoma. Woodruff MF; Hitchcock E; Whitehead VL Br J Cancer; 1977 May; 35(5):687-92. PubMed ID: 861152 [No Abstract] [Full Text] [Related]
9. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents: brief communication. Keller R J Natl Cancer Inst; 1977 Dec; 59(6):1751-3. PubMed ID: 200763 [TBL] [Abstract][Full Text] [Related]
10. Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice. James K; Willmott N; Milne I; McBride WH J Natl Cancer Inst; 1976 May; 56(5):1035-40. PubMed ID: 825650 [TBL] [Abstract][Full Text] [Related]
11. Chemo-immunotherapy of mouse tumours using cyclophosphamide and C. parvum. Scott MT Dev Biol Stand; 1977 Apr 13-15; 38():307-10. PubMed ID: 608516 [TBL] [Abstract][Full Text] [Related]
12. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients. Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869 [No Abstract] [Full Text] [Related]
13. Immune reaction of tumor-bearing mice to Propionibacterium acnes and the antitumor effect of the bacteria. Silobrcic V; Fredrickson G; Sedlacek R; Suit HD; Wolberg G Cancer Immunol Immunother; 1982; 14(1):10-2. PubMed ID: 6925459 [TBL] [Abstract][Full Text] [Related]
14. Combined radiotherapy and Corynebacterium parvum treatment of rat tumors with different immunogenicity. Moroson H; Stowe S; Rotman M; Schechter M Int J Radiat Oncol Biol Phys; 1978; 4(7-8):649-55. PubMed ID: 711536 [No Abstract] [Full Text] [Related]
15. Lysozyme levels and macrophage content of tumor tissue in C3H mice bearing fibrosarcoma transplants treated by radiation and Corynebacterium parvum. Mendiondo O; Suit H; Fixler H Int J Radiat Oncol Biol Phys; 1978; 4(9-10):829-34. PubMed ID: 711553 [No Abstract] [Full Text] [Related]
16. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy. Moore K; McBride WH Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547 [TBL] [Abstract][Full Text] [Related]
17. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells. Bomford R Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344 [TBL] [Abstract][Full Text] [Related]
18. Immunomodulation of chemically induced fibrosarcoma by Corynebacterium parvum. Gupta N; Sehgal S; Aikat BK Indian J Med Res; 1980 Nov; 72():688-95. PubMed ID: 7203570 [No Abstract] [Full Text] [Related]